The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Open accessPublished version of a preprint
Abstract
Recent population studies provide clues that the use of metformin may be associated with reduced incidence and improved prognosis of certain cancers. This drug is widely used in the treatment of type 2 diabetes, where it is often referred to as an "insulin sensitizer" because it not only lowers blood glucose but also reduces the hyperinsulinemia associated with insulin resistance. As insulin and insulin-like growth factors stimulate proliferation of many normal and transformed cell types, agents that facilitate signaling through these receptors would be expected to enhance proliferation. We show here that metformin acts as a growth inhibitor rather than an insulin sensitizer for epithelial cells. Breast cancer cells can be protected against metformin-induced growth inhibition by small interfering RNA against AMP kinase. This shows that AMP kinase pathway activation by metformin, recently shown to be necessary for metformin inhibition of gluconeogenesis in hepatocytes, is also involved in metformin-induced growth inhibition of epithelial cells. The growth inhibition was associated with decreased mammalian target of rapamycin and S6 kinase activation and a general decrease in mRNA translation. These results provide evidence for a mechanism that may contribute to the antineoplastic effects of metformin suggested by recent population studies and justify further work to explore potential roles for activators of AMP kinase in cancer prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of these mechanisms may be through inhibition of cell growth [148], IGF-1 signaling [149], inhibition of the mTOR pathway [150], reduction of human epidermal growth factor receptor type 2 (HER-2) expression (a major driver of proliferation in breast cancer) [151], inhibition of angiogenesis and inflammation [152], induction of apoptosis and protein 53 (p53) activation [153], cell cycle arrest”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [150]
In the citing paper
“and interference with glucose(266), protein(267, 268), and lipid(269) metabolism of the neoplastic cells.”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [268]
In the citing paper
“In laboratory studies, metformin has been shown to inhibit cell proliferation, reduce colony formation, and cause partial cell cycle arrest in cancer cell lines (81–83).”
From Diabetes and Cancer (2010) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Insulin-like growth factors and neoplasia
Pollak, M., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1387 · Cited by 1,477
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 978
Cited by
Sorted by citations
Items 101–200 of 1,000
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Goodwin, P. J., Pritchard, K. I., Ennis, M., Clemons, M. J., Graham, M., & Fantus, I. G. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.060 · Cited by 234
Self-citationLKB1; linking cell structure and tumor suppression
Hezel, A. F., & Bardeesy, N. M. (2008) · Oncogene · doi:10.1038/onc.2008.342 · Cited by 237
Insulin receptor expression by human prostate cancers
Cox, M., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O. S., Fazli, L., & Pollak, M. (2008) · The Prostate · doi:10.1002/pros.20852 · Cited by 224
Self-citationThe key role of growth hormone-insulin-IGF-1 signaling in aging and cancer
Anisimov, V. N., & Bartke, A. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.01.005 · Cited by 192
Preventive therapy for breast cancer: a consensus statement
Cuzick, J. M., DeCensi, A., Arun, B. K., Brown, P. H., Castiglione, M. M., Dunn, B., Forbes, J., Glaus, A., Howell, A., von Minckwitz, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70030-4 · Cited by 225
Sanli, T., Rashid, A., Liu, C., Harding, S. M., Bristow, R. G., Cutz, J.-C., Singh, G., Wright, J. R., & Tsakiridis, T. K. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.005 · Cited by 216
Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
Chlebowski, R. T., McTiernan, A., Wactawski‐Wende, J., Manson, J. E., Aragaki, A. K., Rohan, T. E., Ipp, E., Kaklamani, V., Vitolins, M. Z., Wallace, R. B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7505 · Cited by 218
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
Griss, T., Vincent, E. E., Egnatchik, R. A., Chen, J., Ma, E. H., Faubert, B., Viollet, B., DeBerardinis, R. J., & Jones, R. G. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002309 · Cited by 216
Zakikhani, M., Blouin, M.-J., Piura, E., & Pollak, M. N. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0763-9 · Cited by 213
Self-citationMetformin: A Therapeutic Opportunity in Breast Cancer
Gonzalez-Angulo, A. M., & Meric‐Bernstam, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1805 · Cited by 211
Zhang, H., Zhai, Z., Wang, Y., Zhang, J., Wu, H., Wang, Y., Li, C., Li, D., Lu, L., Wang, X., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.530 · Cited by 212
He, X., Esteva, F. J., Ensor, J., Hortobágyi, G. N., Lee, M., & Yeung, S. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr534 · Cited by 206
Distinct perturbation of the translatome by the antidiabetic drug metformin
Larsson, O. S., Morita, M., Topisirović, I., Alain, T., Blouin, M., Pollak, M., & Sonenberg, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201689109 · Cited by 205
Self-citationDual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
Isaković, A., Harhaji-Trajkovic, L. M., Stevanovic, D., Marković, Z. M., Šumarac-Dumanović, M., Starcevic, V. P., Micić, D., & Trajković, V. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7080-4 · Cited by 210
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Lee, J. H., Kim, T. I., Jeon, S. M., Hong, S. P., Cheon, J. H., & Kim, W. H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26421 · Cited by 206
Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
Gallagher, E. J., & LeRoith, D. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06285.x · Cited by 208
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua, Y., Zheng, Y., Yao, Y., Jia, R., Ge, S., & Zhuang, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04263-8 · Cited by 220
Chen, G., Xu, S., Renko, K., & Derwahl, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1754 · Cited by 196
Critical role of AMPK in redox regulation under glucose starvation
Ren, Y., & Shen, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101154 · Cited by 201
Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics
McKinnon, B. D., Kocbek, V., Nirgianakis, K., Bersinger, N. A., & Mueller, M. D. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv060 · Cited by 195
Jeninga, E. H., Schoonjans, K., & Auwerx, J. H. (2010) · Oncogene · doi:10.1038/onc.2010.206 · Cited by 197
Tsilidis, K. K., Capothanassi, D., Allen, N. E., Rizos, E. C., López, D. S., van Veldhoven, K., Sacerdote, C., Ashby, D., Vineis, P., Tzoulaki, I., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0584 · Cited by 192
Potential applications for biguanides in oncology
Pollak, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67232 · Cited by 194
Self-citationPharmacotherapy of type 2 diabetes: An update
Upadhyay, J., Pοlyzos, S. A., Perakakis, N., Thakkar, B., Paschou, S. Α., Katsiki, N., UNDERWOOD, P. C., Park, K., Seufert, J., Kang, E. S., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.010 · Cited by 196
The Role of Metformin in the Management of NAFLD
Mazza, A., Fruci, B., Garinis, G. A., Giuliano, S., Malaguarnera, R., & Belfiore, A. (2011) · Experimental Diabetes Research · doi:10.1155/2012/716404 · Cited by 189
Metformin suppresses intestinal polyp growth in Apc Min/+ mice
Tomimoto, A., Endo, H., Sugiyama, M., Fujisawa, T., Hosono, K., Takahashi, H., Nakajima, N., Nagashima, Y., Wada, K., Nakagama, H., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00933.x · Cited by 185
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
Algire, C., Zakikhani, M., Blouin, M.-J., Shuai, J. H., & Pollak, M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0038 · Cited by 185
Self-citationGlioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
Sato, A., Sunayama, J., Okada, M., Watanabe, E., Seino, S., Shibuya, K., Suzuki, K., Narita, Y., Shibui, S., Kayama, T., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0058 · Cited by 189
Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer
Menéndez, J. A., Vázquez‐Martín, A., Ortega, F. J., & Fernández‐Real, J. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115352 · Cited by 182
Venkateswaran, V. K., Haddad, A., Fleshner, N. E., Fan, R., Sugar, L., Nam, R. K., Klotz, L. H., & Pollak, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm231 · Cited by 190
Self-citationAlgire, C., Amrein, L., Bazile, M., David, S., Zakikhani, M., & Pollak, M. (2010) · Oncogene · doi:10.1038/onc.2010.483 · Cited by 186
Self-citationSpratt, D. E., Zhang, C., Zumsteg, Z. S., Pei, X., Zhang, Z., & Zeléfsky, M. J. (2012) · European Urology · doi:10.1016/j.eururo.2012.12.004 · Cited by 184
Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Uchiyama, T., Suzuki, K., Nozaki, Y., Yoneda, K., Fujita, K., Yoneda, M., et al. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20637 · Cited by 181
Goodwin, P. J., Stambolic, V., Lemieux, J., Chen, B. E., Parulekar, W. R., Gelmon, K. A., Hershman, D. L., Hobday, T. J., Ligibel, J. A., Mayer, I. A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1224-1 · Cited by 178
Home, P. D., Kahn, S. E., Jones, N. P., Noronha, D., Beck‐Nielsen, H., & Viberti, G. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1804-y · Cited by 176
Martinez‐Outschoorn, U., Goldberg, A. F., Zhao, L., Ko, Y., Flomenberg, N., Wang, C., Pavlides, S., Pestell, R. G., Howell, A., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.10.17780 · Cited by 180
Taliaferro-Smith, L., Nagalingam, A., Zhong, D., Zhou, W., Saxena, N. K., & Sharma, D. (2009) · Oncogene · doi:10.1038/onc.2009.129 · Cited by 173
Phoenix, K. N., Vumbaca, F., & Claffey, K. P. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9916-5 · Cited by 173
Kim, H. G., Hiền, T. T., Han, E. H., Hwang, Y. P., Choi, J. H., Kang, K. W., Kwon, K., Kim, B., Kim, S. K., Song, G., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01101.x · Cited by 175
Truong, M., Kim, H. G., Choi, J. H., & Jeong, H. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.010 · Cited by 172
Anisimov, V. N., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Tyndyk, M. L., Yurova, M. N., Zabezhinski, M. A., Anikin, I. V., Karkach, A. S., & Romanyukha, A. A. (2010) · Cell Cycle · doi:10.4161/cc.9.1.10407 · Cited by 146
Histological evaluation of AMPK signalling in primary breast cancer
Hadad, S. M., Baker, L., Quinlan, P., Robertson, K. E., Bray, S. E., Thomson, G., Kellock, D., Jordan, L. B., Purdie, C. A., Hardie, D. G., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-307 · Cited by 177
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
Zhao, Y. D., Wang, W., Guo, S., Wang, Y., Miao, L., Xiong, Y., & Huang, L. (2016) · Nature Communications · doi:10.1038/ncomms11822 · Cited by 173
Afzal, M. Z., Mercado, R. R., & Shirai, K. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0375-1 · Cited by 173
Bowker, S. L., Yasui, Y., Veugelers, P. J., & Johnson, J. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1750-8 · Cited by 166
The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Hsieh, M.-C., Lee, T.-C., Cheng, S.-M., Tu, S., Yen, M., & Tseng, C. (2012) · Experimental Diabetes Research · doi:10.1155/2012/413782 · Cited by 166
Tan, B., Yao, W., Ge, J., Peng, X., Du, X., Zhang, R., Yao, B., Xie, K., Li, L., Dong, H., et al. (2011) · Cancer · doi:10.1002/cncr.26151 · Cited by 161
AMP‐activated protein kinase and cancer
Wang, W., & Guan, K. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01980.x · Cited by 167
Autophagy as a modulator and target in prostate cancer
Farrow, J. M., Yang, J. C., & Evans, C. P. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.196 · Cited by 167
Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates
Gronich, N., & Rennert, G. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.169 · Cited by 167
Anticancer Activity of Metformin: A Systematic Review of the Literature
Aljofan, M., & Riethmacher, D. (2019) · Future Science OA · doi:10.2144/fsoa-2019-0053 · Cited by 163
Use of metformin and the risk of ovarian cancer: A case–control analysis
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.038 · Cited by 158
Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?
Xu, Y., Xue, D., Bankhead, A., & Neamati, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01013 · Cited by 173
Yin, M., Zhou, J., Gorak, E. J., & Quddus, F. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0111 · Cited by 157
Differential effects of AMPK agonists on cell growth and metabolism
Vincent, E. E., Coelho, P. P., Blagih, J., Griss, T., Viollet, B., & Jones, R. G. (2014) · Oncogene · doi:10.1038/onc.2014.301 · Cited by 161
Targeted Therapy for Breast Cancer Prevention
den Hollander, P., Savage, M. I., & Brown, P. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00250 · Cited by 161
Targeting AMPK: A new therapeutic opportunity in breast cancer
Hadad, S. M., Fleming, S., & Thompson, A. M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.007 · Cited by 158
Targeting the Metabolic Microenvironment of Tumors
Bailey, K. M., Wojtkowiak, J. W., Hashim, A. I., & Gillies, R. J. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00004-x · Cited by 157
He, X., Tu, S., Lee, M., & Yeung, S. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr020 · Cited by 153
Metformin Targets Multiple Signaling Pathways in Cancer
Lei, Y., Yi, Y., Liu, Y., Liu, X., Keller, E. T., Qian, C.-N., Zhang, J., & Lu, Y. (2017) · Chinese Journal of Cancer · doi:10.1186/s40880-017-0184-9 · Cited by 152
Garrett, C. R., Hassabo, H. M., Bhadkamkar, N. A., Wen, S., Baladandayuthapani, V., Kee, B. K., Eng, C., & Hassan, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.71 · Cited by 153
Metformin and cancer: An existing drug for cancer prevention and therapy (Review)
Zi, F., Zi, H., Li, Y., He, J., Shi, Q., & Cai, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7412 · Cited by 156
Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
Bhalla, K., Hwang, B. J., Dewi, R. E., Twaddel, W., Goloubeva, O. G., Wong, K., Saxena, N. K., Biswal, S. S., & Girnun, G. D. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0228 · Cited by 152
p53 and metabolism: from mechanism to therapeutics
Simabuco, F. M., Morale, M. G., Pavan, I. C. B., Morelli, A. P., Silva, F. R., & Tamura, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.25267 · Cited by 159
Chaiteerakij, R., Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Mettler, T. A., Fredericksen, Z. S., Kim, W. R., Gores, G. J., Roberts, R. O., Olson, J. E., et al. (2012) · Hepatology · doi:10.1002/hep.26092 · Cited by 150
Hanna, R. K., Zhou, C., Malloy, K., Sun, L., Zhong, Y., Gehrig, P. A., & Bae-Jump, V. L. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.01.009 · Cited by 150
Bosco, J. L. F., Antonsen, S., Sørensen, H. T., Pedersen, L. H., & Lash, T. L. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0817 · Cited by 148
Obesity and cancer, a case for insulin signaling
Poloz, Y., & Stambolic, V. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.381 · Cited by 154
Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
Gill, K. S., Fernandes, P., O’Donovan, T. R., McKenna, S. L., Doddakula, K., Power, D. G., Soden, D. M., & Forde, P. F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.005 · Cited by 149
Liu, B., Fan, Z., Edgerton, S. M., Yang, X., Lind, S. E., & Thor, A. D. (2011) · Cell Cycle · doi:10.4161/cc.10.17.16359 · Cited by 120
Jung, J., Park, S., Lee, S., Seo, M., Trosko, J. E., & Kang, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028068 · Cited by 145
Marini, C., Salani, B., Massollo, M., Amaro, A. A., Esposito, A. I., Orengo, A. M., Capitanio, S., Emionite, L., Riondato, M., Bottoni, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.26461 · Cited by 145
Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis
Kang, K. Y., Kim, Y., Yi, H., Kim, J., Jung, H., Kim, I. J., Cho, J., Park, S., Kim, H., & Ju, J. H. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.03.020 · Cited by 145
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
Johnson, J. A., & Bowker, S. L. (2010) · Diabetologia · doi:10.1007/s00125-010-1933-3 · Cited by 145
Metabolic Roles of AMPK and Metformin in Cancer Cells
Choi, Y. K., & Park, K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0169-8 · Cited by 150
Vitale-Cross, L. A., Molinolo, A., Martín, D., Younis, R. H., Maruyama, T., Patel, V., Chen, W., Schneider, A., & Gutkind, J. S. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0502 · Cited by 145
Mohammed, A., Janakiram, N. B., Brewer, M., Ritchie, R. L., Marya, A., Lightfoot, S., Steele, V. E., & Rao, C. V. (2013) · Translational Oncology · doi:10.1593/tlo.13556 · Cited by 142
Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A
Martin, M. J., Hayward, R., Virós, A., & Marais, R. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0280 · Cited by 152
Diabetes and Pancreatic Cancer: Chicken or Egg?
Magruder, J. T., Elahi, D., & Andersen, D. K. (2011) · Pancreas · doi:10.1097/mpa.0b013e318209e05d · Cited by 140
Metformin for aging and cancer prevention
Anisimov, V. N. (2010) · Aging · doi:10.18632/aging.100230 · Cited by 142
Serine deprivation enhances antineoplastic activity of biguanides
Gravel, S.-P., Hulea, L., Toban, N., Birman, E., Blouin, M.-J., Zakikhani, M., Zhao, Y., Topisirovic, I., St-Pierre, J., & Pollak, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2643-t · Cited by 138
Self-citationLactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA
Chen, J. L.-Y., Merl, D., Peterson, C. W., Wu, J., Liu, P. Y., Yin, H., Muoio, D. M., Ayer, D. E., West, M., & Chi, J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001093 · Cited by 136
Control of Cell Survival and Proliferation by Mammalian Eukaryotic Initiation Factor 4B
Shahbazian, D., Parsyan, A. E., Petroulakis, E., Topisirović, I., Martineau, Y., Gibbs, B. F., Svitkin, Y. V., & Sonenberg, N. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01218-09 · Cited by 137
Self-citationMetabolic requirements for cancer cell proliferation
Keibler, M. A., Wasylenko, T. M., Kelleher, J. K., Iliopoulos, O., Heiden, M. G. V., & Stephanopoulos, G. N. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0156-6 · Cited by 141
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
Wang, C.-P., Lorenzo, C., Habib, S. L., Jo, B., & Espinoza, S. E. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.013 · Cited by 134
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Cazzaniga, M., Bonanni, B., Guerrieri‐Gonzaga, A., & DeCensi, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0871 · Cited by 134
Delivery Systems for Nucleic Acids and Proteins: Barriers, Cell Capture Pathways and Nanocarriers
Torres-Vanegas, J. D., Cruz, J. C., & Reyes, L. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030428 · Cited by 142
Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial
Mitsuhashi, A., Kiyokawa, T., Sato, Y., & Shozu, M. (2014) · Cancer · doi:10.1002/cncr.28853 · Cited by 129
Tan, B. K., Adya, R., Chen, J., Lehnert, H., Cassia, L. J. S., & Randeva, H. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1803 · Cited by 129
Karnevi, E., Said, K., Andersson, R., & Rosendahl, A. H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-235 · Cited by 99
Metformin, cancer and glucose metabolism
Salani, B., Río, A. D., Marini, C., Sambuceti, G., Cordera, R., & Maggi, D. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0284 · Cited by 129
Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice
Xu, G., Wu, H., Zhang, J., Li, D., Wang, Y., Wang, Y., Zhang, H., Lu, L., Li, C., Huang, S. M., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.045 · Cited by 132
Association between diabetes, diabetes treatment and risk of developing endometrial cancer
Luo, J., Beresford, S. A. A., Chen, C., Chlebowski, R. T., García, L., Kuller, L. H., Regier, M., Wactawski‐Wende, J., & Margolis, K. L. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.407 · Cited by 133
Anisimov, V. N., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Тындык, М. Л., Egormin, P. A., Yurova, M. N., Rosenfeld, S. V., Semenchenko, A. V., Kovalenko, I. G., et al. (2010) · Aging · doi:10.18632/aging.100245 · Cited by 128
Glucose Promotes Breast Cancer Aggression and Reduces Metformin Efficacy
Wahdan-Alaswad, R., Fan, Z., Edgerton, S. M., Liu, B., Deng, X.-S., Arnadottir, S. S., Richer, J. K., Anderson, S. M., & Thor, A. D. (2013) · Cell Cycle · doi:10.4161/cc.26641 · Cited by 125
Metformin and neoplasia: Implications and indications
Aljada, A., & Mousa, S. A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.004 · Cited by 128
Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
Rattan, R., Fehmi, R.-A., & Munkarah, A. R. (2012) · Journal of Oncology · doi:10.1155/2012/928127 · Cited by 126
Metformin in breast cancer: preclinical and clinical evidence
De, A., & Kuppusamy, G. (2019) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2019.06.003 · Cited by 126
Truong, M., Kim, H. G., Khanal, T., Choi, J. H., Kim, D. H., Jeong, T. C., & Jeong, H. G. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.010 · Cited by 124
Rothermundt, C. A., Hayoz, S., Templeton, A. J., Winterhalder, R., Strebel, R. T., Bärtschi, D., Pollak, M., Lui, L., Endt, K., Schiess, R., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.12.057 · Cited by 123
Self-citation
Metadata
- Authors
- Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M.
- Affiliations
- 1Oncology and Departments of
- McGill University (CA)
- Mount Sinai Hospital (CA)
- Venue
- Cancer Research
- Published
- 2006-11-01
- Volume
- 66
- Issue
- 21
- Pages
- 10269-10273
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2078190084
- Cited by
- 1,048
- References
- 20
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 24 · 2023: 29 · 2022: 28 · 2021: 54 · 2020: 47 · 2019: 62 · 2018: 55 · 2017: 70 · 2016: 70 · 2015: 80 · 2014: 93 · 2013: 86 · 2012: 85
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Canadian Breast Cancer Research Alliance
- Terry Fox Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- metformin, AMP kinase, breast cancer, cell growth inhibition, antineoplastic effects, mTOR, S6 kinase, mRNA translation, insulin resistance, insulin-like growth factor, epithelial cells, cancer prevention
- MeSH terms
- Adenylate Kinase, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Insulin, Metformin, Protein Biosynthesis, Gene Expression Regulation, Enzymologic, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
